Minerva Surgical Q2 EPS $(0.05) Beats $(0.09) Estimate, Sales $13.40M Miss $13.92M Estimate
Portfolio Pulse from Benzinga Newsdesk
Minerva Surgical reported Q2 earnings per share (EPS) of $(0.05), beating the analyst consensus estimate of $(0.09) by 44.44%. However, the company's quarterly sales of $13.40 million missed the analyst consensus estimate of $13.92 million by 3.74%. This represents a 75% increase in EPS and a 3.34% increase in sales compared to the same period last year.
August 04, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Minerva Surgical's Q2 results showed a mixed performance with EPS beating estimates but sales missing them. This could lead to mixed investor sentiment.
Minerva Surgical's EPS beat estimates, which is a positive signal for investors. However, the company's sales missed estimates, which could be a concern. The net effect on the stock price could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100